A prospective pilotstudy comparing the anesthetic effects of an alpha-2 agonist during holmium laser resection of the prostate and transurethral resection for prostate surgery for benign prostatic hyperplasia patients using selective alpha-1 blockers

[1]  C. Arndt,et al.  Bispectral index to guide induction of anesthesia: a randomized controlled study , 2018, BMC Anesthesiology.

[2]  Steven A Julious,et al.  Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable , 2015, Statistical methods in medical research.

[3]  S. Ok,et al.  Dexmedetomidine-induced Contraction Involves Phosphorylation of Caldesmon by JNK in Endothelium-denuded Rat Aortas , 2014, International journal of biological sciences.

[4]  Y. Yoon,et al.  Effects of intravenous dexmedetomidine on low‐dose bupivacaine spinal anaesthesia in elderly patients , 2012, Acta anaesthesiologica Scandinavica.

[5]  R. Bruskewitz,et al.  Benign Prostatic Hyperplasia , 2012, Drugs.

[6]  R. Nunes,et al.  Bispectral index and other processed parameters of electroencephalogram: an update. , 2012, Revista brasileira de anestesiologia.

[7]  T. Bates,et al.  Pre-operative risk scores for the prediction of outcome in elderly people who require emergency surgery , 2007, World journal of emergency surgery : WJES.

[8]  K. McVary.  BPH: epidemiology and comorbidities. , 2006, The American journal of managed care.

[9]  D. Quartermain,et al.  α1-Adrenergic and α2-adrenergic balance in the dorsal pons and gross behavioral activity of mice in a novel environment , 2005, Psychopharmacology.

[10]  D. Quartermain,et al.  Alpha(1)-adrenergic and alpha(2)-adrenergic balance in the dorsal pons and gross behavioral activity of mice in a novel environment. , 2005, Psychopharmacology.

[11]  J. Sanders,et al.  Alpha-2 adrenergic receptor development in rat CNS: an autoradiographic study , 2004, Neuroscience.

[12]  L. Nazarko.  Benign prostatic hyperplasia: Diagnosis and treatment , 2004 .

[13]  D. Quartermain,et al.  Role of epinephrine stimulation of CNS α1‐adrenoceptors in motor activity in mice , 2003 .

[14]  D. H. Mitchell,et al.  Dexmedetomidine: A Novel Sedative-Analgesic Agent , 2001, Proceedings.

[15]  C. Roehrborn,et al.  Benign prostatic hyperplasia. , 2020, BMJ.

[16]  A. Tewari,et al.  Alpha-adrenergic blocking drugs in the management of benign prostatic hyperplasia: interactions with antihypertensive therapy. , 1999, Urology.

[17]  M. Wyllie,et al.  Prostatic α1‐adrenoceptors and uroselectivity , 1997 .

[18]  P. White,et al.  Electroencephalographic Bispectral Index Correlates with Intraoperative Recall and Depth of Propofol-Induced Sedation , 1997, Anesthesia and analgesia.

[19]  H. Lepor,et al.  Prostatic alpha 1-adrenoceptors and uroselectivity. , 1997, The Prostate.

[20]  Paul F. White,et al.  Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. , 1996 .

[21]  Bruskewitz Rc,et al.  Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research. , 1994 .

[22]  S. Carruthers.  Adverse Effects of α1-Adrenergic Blocking Drugs , 1994 .

[23]  R. Bruskewitz,et al.  Benign prostatic hyperplasia. Current pharmacological treatment. , 1994, Drugs.

[24]  S. Carruthers.  Adverse effects of alpha 1-adrenergic blocking drugs. , 1994, Drug safety.

[25]  R C Bruskewitz,et al.  Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research. , 1994, Clinical practice guideline. Quick reference guide for clinicians.

[26]  A T Cockett,et al.  Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. , 1993, The Journal of urology.

[27]  Y. Shiraiwa,et al.  Clinical evaluation of effects of prazosin in patients with benign prostatic obstruction. A double-blind, multi-institutional, Paraprost-controlled study. , 1990, Urologia internationalis.

[28]  J. McGrath,et al.  Pharmacological analysis of postjunctional α‐adrenoceptors mediating contractions to (−)‐noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of α1‐and α2‐adrenoceptors , 1988 .

[29]  J. Savola,et al.  Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. , 1988, European journal of pharmacology.

[30]  J. McGrath,et al.  Pharmacological analysis of postjunctional alpha-adrenoceptors mediating contractions to (-)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of alpha 1- and alpha 2-adrenoceptors. , 1988, British journal of pharmacology.

[31]  H. Lepor,et al.  Alpha 2 adrenergic receptors in hyperplastic human prostate: identification and characterization using [3H] rauwolscine. , 1986, The Journal of urology.

[32]  K. Andersson,et al.  Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate. , 1985, The Journal of urology.

[33]  M. Kuhar,et al.  Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents , 1984, Brain Research Reviews.

[34]  K. Andersson,et al.  Effects of prazosin in patients with benign prostatic obstruction. , 1983, The Journal of urology.